InpharmD™ provides a platform for clinical pharmacists to submit specific medical inquiries, enabling a tailored literature search that delivers curated, evidence-based responses. This service significantly reduces the time spent on research, allowing healthcare professionals to focus more on patient care, with a reported 85,850 clinical pharmacist hours saved.
Funding
$6.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.


Founders
Product
Problem
Clinical pharmacists often spend significant time conducting literature searches to answer specific medical inquiries, diverting their attention from direct patient care. This time-consuming process can delay access to crucial drug information and potentially impact patient outcomes.
Solution
InpharmD provides a platform that enables clinical pharmacists to submit specific medical inquiries and receive curated, evidence-based responses, significantly reducing literature search time. By leveraging a combination of AI and expert clinical pharmacists, InpharmD delivers customized, actionable drug information in real time. This allows healthcare professionals to focus more on patient care, stay informed about emerging data and price changes, and make faster, more informed decisions with confidence. The platform helps teams stay informed immediately when new data emerges or prices change, ensuring they are always the first to know when any changes impact their formulary.
Target Audience
The primary users are clinical pharmacists, physicians, nurse practitioners, and physician assistants seeking quick, evidence-based answers to drug information questions.
Features
- Custom literature searches performed by clinical pharmacists and AI
- Curated, evidence-based responses to specific medical inquiries
- Real-time drug information updates, including new data and price changes
- Summaries of relevant studies with citations
- Tables provided from studies used to formulate responses
- Coverage of indications to treat adverse effects of various drugs in similar classes